[1]
“Diagnostic assessment program for prostate cancer: Lessons learned after 2 years and degree of compliance to Canadian guidelines”, Arch Ital Urol Androl, vol. 93, no. 4, pp. 389–392, Dec. 2021, doi: 10.4081/aiua.2021.4.389.